Xiangxue PharmaceuticalLtd 대차 대조표 상태
재무 상태 기준 확인 2/6
Xiangxue PharmaceuticalLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 108.6%. Its total assets and total liabilities are CN¥8.1B and CN¥5.9B respectively.
주요 정보
108.6%
부채 비율
CN¥2.30b
부채
| 이자 보상 비율 | n/a |
| 현금 | CN¥75.60m |
| 주식 | CN¥2.12b |
| 총 부채 | CN¥5.94b |
| 총 자산 | CN¥8.05b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%
Oct 15
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 31Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet
Jun 07Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Mar 12재무 상태 분석
단기부채: 300147's short term assets (CN¥1.9B) do not cover its short term liabilities (CN¥5.2B).
장기 부채: 300147's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥780.9M).
부채 대 자본 내역 및 분석
부채 수준: 300147's net debt to equity ratio (105.1%) is considered high.
부채 감소: 300147's debt to equity ratio has increased from 75.5% to 108.6% over the past 5 years.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: 300147 has sufficient cash runway for more than 3 years based on its current free cash flow.
예측 현금 활주로: 300147 has less than a year of cash runway if free cash flow continues to grow at historical rates of 43.9% each year.